Quality of life after therapy for localized prostate cancer

Cancer Journal

Volumn 13, Issue 5, 2007, Pages 318-326

  Penson, David F ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Department of Urology ^*  (United States)

Author keywords

Outcomes; Prostate cancer; Quality of life

Indexed keywords

BRACHYTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; IMPOTENCE; INCONTINENCE; LAPAROSCOPIC SURGERY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; MALE; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 38449083813     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181570121     Document Type: Review

References (79)

1. Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol. 2005;23:8165-8169.
2. Arredondo SA, Downs TM, Lubeck DP, et al. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2004;172:1830-1834.
3. Klein EA. Radiation therapy versus radical prostatectomy in the PSA era: a urologist's view. Semin Radiat Oncol. 1998;8:87-94.
4. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005; 352:1977-1984.
5. Feldman-Stewart D, Brundage MD, Van Manen L, et al. Patient-focussed decision-making in early-stage prostate cancer: insights from a cognitively based decision aid. Health Expect. 2004;7:126-141.
6. Holmboe ES, Concato J. Treatment decisions for localized prostate cancer: asking men what's important. J Gen Med. 2000;15:694-701.
7. Patrick DL, Erickson P. Assessing health-related quality of life for clinical decision-making. In: Walker SR, Rosser RM, eds. Quality of life assessment: key issues in the 1990's. Dordrecht, the Netherlands: Klu-wer Academic Publishers; 1993.
8. Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer. J Urol. 2003;169:1653-1661.
9. Litwin MS, Fitzpatrick JM, Fossa SD, et al. Defining an international research agenda for quality of life in men with prostate cancer. Prostate. 1999;41:58-67.
10. Gill TM, Feinstein AR. A critical appraisal of the quality-of-life measurements. JAMA. 1994;272:619-626.
11. Reeve BB, Potosky AL, Willis GB. Should function and bother be measured and reported separately for prostate cancer quality-of-life domains? Urology. 2006;68:599-603.
12. Korfage IJ, Essink-Bot ML, Borsboom GJ, et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer. 2005;116:291-296.
13. Penson DF, Feng Z, Kuniyuki A, et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol. 2003; 21:1147-1154.
14. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96:1358-1367.
15. van Andel G, Visser AP, Zwinderman AH, et al. A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients. Prostate. 2004;58:354-365.
16. Namiki S, Egawa S, Baba S, et al. Recovery of quality of life in year after laparoscopic or retropubic radical prostatectomy: a multi-institutional longitudinal study. Urology. 2005;65:517-523.
17. Lubeck DP, Litwin MS, Henning JM, et al. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology. 1999;53:180-186.
18. Litwin MS, Gore JL, Kwan L, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007;109:2239-2247.
19. Herrell SD, Smith JA Jr. Laparoscopic and robotic radical prostatectomy: what are the real advantages? BJU Int. 2005;95:3-4.
20. Bhayani SB, Pavlovich CP, Hsu TS, et al. Prospective comparison of short-term convalescence: laparoscopic radical prostatectomy versus open radical retropubic prostatectomy. Urology. 2003;61:612-616.
21. Namiki S, Egawa S, Terachi T, et al. Changes in quality of life in first year after radical prostatectomy by retropubic, laparoscopic, and peri-neal approach: multi-institutional longitudinal study in Japan. Urology. 2006;67:321-327.
22. Korfage IJ, de Koning HJ, Roobol M, et al. Prostate cancer diagnosis: the impact on patients' mental health. Eur J Cancer. 2006;42:165-170.
23. Bacon CG, Giovannucci E, Testa M, et al. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer. 2002;94:862-871.
24. Wei JT, Dunn RL, Marcovich R, et al. Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol. 2000; 164:744-748.
25. Eastham JA, Kattan MW, Rogers E, et al. Risk factors for urinary incontinence after radical prostatectomy [see comments]. J Urol. 1996; 156:1707-1713.
26. Ellison L, Heaney J, Birkmeyer J. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol. 2000; 163:867-869.
27. Potosky AL, Harlan LC, Stanford JL, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999;91:1719-1724.
28. Penson DF, McLerran D, Feng Z, et al. Five-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol. 2005;173:1701-1705.
29. Kao T, Cruess D, Garner D, et al. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. J Urol. 2000;163:858-864.
30. Litwin MS, Flanders SC, Pasta DJ, et al. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE: Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1999;54:503-508.
31. Menon M, Shrivastava A, Kaul S, et al. Vattikuti Institute prostatectomy: contemporary technique and analysis of results. Eur Urol. 51: 648-657, 2007; discussion 657-658.
32. Hara I, Kawabata G, Miyake H, et al. Comparison of quality of life following laparoscopic and open prostatectomy for prostate cancer. J Urol. 2003;169:2045-2048.
33. Schmeller N, Keller H, Janetschek G. Head-to-head comparison of retropubic, perineal and laparoscopic radical prostatectomy. Int J Urol. 2007;14:402-405.
34. Ball AJ, Gambill B, Fabrizio MD, et al. Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution. J Endourol. 2006;20:723-731.
35. Tewari A, Srivasatava A, Menon M. A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution. BJU Int. 2003;92:205-210.
36. Tseng TY, Kuebler HR, Cancel QV, et al. Prospective health-related quality-of-life assessment in an initial cohort of patients undergoing robotic radical prostatectomy. Urology. 2006;68:1061-1066.
37. Litwin MS, Melmed GY, Nakazon T. Life after radical prostatectomy: a longitudinal study. J Urol. 2001;166:587-592.
38. Fransson P, Widmark A. Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls. Cancer. 1999;85:678-688.
39. Franklin CI, Parker CA, Morton KM. Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity. Australas Radiol. 1998;42:58-65.
40. Mantz CA, Nautiyal J, Awan A, et al. Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoad-juvant androgen blockade, treatment technique, and patient-related factors [see comments]. Cancer J Sci Am. 1999;5:230-236.
41. Helgason AR, Adolfsson J, Dickman P, et al. Waning sexual function - the most important disease-specific distress for patients with prostate cancer. Br J Cancer. 1996;73:1417-1421.
42. Hamilton AS, Stanford JL, Gilliland FD, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001; 19:2517-2526.
43. Potosky AL, Davis WW, Hoffman RM, et al. Five year outcomes following surgery versus radiotherapy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study (PCOS). J Natl Cancer Inst. 2004;96:1358-1367.
44. Lips I, Dehnad H, Kruger AB, et al. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study. Int J Radiat Oncol Biol Phys. In press.
45. Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer. 1994;74:2520-2532.
46. Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology. 1996;47:387-394.
47. Geinitz H, Zimmermann FB, Thamm R, et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. Radiother Oncol. 2006;79:341-347.
48. Arredondo SA, Latini DM, Sadetsky N, et al. Quality of life for men receiving a second treatment for prostate cancer. J Urol. 177:273-278, 2007; discussion 278-279.
49. Zeliadt SB, Potosky AL, Penson DF, et al. Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:395-402.
50. Lee WR, McQuellon RP, Case LD, et al. Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer. J Urol. 1999;162:403-406.
51. Lee WR, McQuellon RP, Harris-Henderson K, et al. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2000;46:77-81.
52. Locke J, Ellis W, Wallner K, et al. Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study. Int J Radiat Oncol Biol Phys. 2002;52:712-719.
53. Buron C, Le Vu B, Cosset JM, et al. Brachytherapy versus prostatec- tomy in localized prostate cancer: results of a French multicenter prospective medico-economic study. Int J Radiat Oncol Biol Phys. 2007;67:812-822.
54. Speight JL, Elkin EP, Pasta DJ, et al. Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE. Int J Radiat Oncol Biol Phys. 2004;60:1066-1075.
55. Arterbery VE, Frazier A, Dalmia P, et al. Quality of life after permanent prostate implant. Semin Surg Oncol. 1997;13:461-464.
56. Talcott JA, Clark JA, Stark PC, et al. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol. 2001;166:494-499.
57. Hollenbeck BK, Dunn RL, Wei JT, et al. Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy. Urology. 2002;59:480-484.
58. Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20:557-566.
59. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachyther-apy. J Clin Oncol. 2005;23:2772-2780.
60. Jonler M, Nielsen OS, Wolf H. Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment. Urology. 52:1055-1062, 1998; discussion 1063.
61. Hoffman RM, Gilliland FD, Penson DF, et al. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls. Cancer. 2004;101: 2011-2019.
62. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347: 790-796.
63. McCammon KA, Kolm P, Main B, et al. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology. 1999;54:509-516.
64. Frank SJ, Pisters LL, Davis J, et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol. 177:2151-2156, 2007; discussion 2156.
65. Lim AJ, Brandon AH, Fiedler J, et al. Quality of life: radical prostatectomy versus radiation therapy for prostate cancer [see comments]. J Urol. 1995;154:1420-1425.
66. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129-135.
67. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol. 1996;14:2258-2265.
68. Shrader-Bogen CL, Kjellberg JL, McPherson CP, et al. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer. 1997;79:1977-1986.
69. Akakura K, Isaka S, Akimoto S, et al. Long-term results of a randomized trial for the treatment of stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. Urology. 1999;54:313-318.
70. Litwin MS, Pasta DJ, Yu J, et al. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol. 2000;164:1973-1977.
71. Brandeis JM, Litwin MS, Burnison CM, et al. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol. 2000;163: 851-857.
72. Krupski T, Petroni G, Bissonette E, et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinical localized prostate cancer. Urology. 2000;55:736-742.
73. Potosky AL, Legler J, Albertsen PC, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000;92:1582-1592.
74. Bacon CG, Giovannucci E, Testa M, et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol. 2001;166:1804-1810.
75. Davis JW, Kuban DA, Lynch DF, et al. Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol. 2001;166:962-963.
76. Galbreath ME, Ramirez JM, Pedro LW. Quality of life, health outcomes, and identity for patients with prostate cancer in five different treatment groups. Oncol Nurs Forum. 2001;28:551-560.
77. Madalinska JB, Essink-Bot ML, de Koning HJ, et al. Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment. Prostate. 2001;46: 87-97.
78. Lee WR, Hall MC, McQuellon RP, et al. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachy-therapy. Int J Radiat Oncol Biol Phys. 2001;51:614-623.
79. Schapira MM, Lawrence WF, Katz DA, et al. Effect of treatment on quality of life among men with clinically localized prostate cancer. Med Care. 2001;39:243-253.